Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Shares Issued
Ratios

Bone Biologics (BBLG) Shares Outstanding (2016 - 2017)

Bone Biologics has reported Shares Outstanding over the past 3 years, most recently at $4.3 million for Q4 2017.

  • Quarterly Shares Outstanding rose 11.47% to $4.3 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2017, up 11.47% year-over-year, with the annual reading at $4.3 million for FY2017, 11.47% up from the prior year.
  • Shares Outstanding was $4.3 million for Q4 2017 at Bone Biologics, down from $39.1 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $39.1 million in Q3 2017 and troughed at $3.9 million in Q4 2016.
  • The 3-year median for Shares Outstanding is $38.8 million (2016), against an average of $30.3 million.
  • Year-over-year, Shares Outstanding crashed 87.95% in 2016 and then grew 11.47% in 2017.
  • A 3-year view of Shares Outstanding shows it stood at $32.2 million in 2015, then crashed by 87.95% to $3.9 million in 2016, then grew by 11.47% to $4.3 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Shares Outstanding are $4.3 million (Q4 2017), $39.1 million (Q3 2017), and $38.8 million (Q2 2017).